Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1804289Erstellt: 26. Oktober 2026

(R)-4-Methyloxazolidin-2-one → (R)-3-{3-(3-acetyl-2-oxoimidazolidin-1-yl)-4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one

https://huagongshe.com/reaction/1804289

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt(R)-4-Methyloxazolidin-2-oneHCID 2734858—
Edukt1-Acetyl-3-{5-chloro-2-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}imidazolidin-2-oneHCID 58484683—
Produkt(R)-3-{3-(3-acetyl-2-oxoimidazolidin-1-yl)-4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-oneHCID 5848464011,8%

Reaktionsschritte

By reaction and treatment in the same manner as in Example 201 and using 1-acetyl-3-{5-chloro-2-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}imidazolidin-2-one (519 mg) described in Preparation Example 126 and (R)-4-methyloxazolidin-2-one (115 mg) described in Preparation Example 25, the title compound (69.9 mg) was obtained.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08354401B2
Quelldatensatzuspto-grants-2013_01
ORD IDord-f6aaf0ea394b4710977984fb5cf055f2
Quellennotizuspto-grants-2013_01